Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4207.30 +0.9% SILVER 57.77 +1.1% COPPER 6.61 +0.8% OIL 95.90 −2.1% PALLADIUM 1129.75 +0.1% OMI 0.250 +0.0% BUFF 0.810 +3.9% FEO 0.650 +0.0% LIB 0.750 +4.2% NPR 0.630 +1.6% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.540 +3.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.55 −2.8% CASA 0.060 +0.0% DRY 0.225 +4.7% SOMA 0.550 −1.8% PWRO 0.025 +0.0% GOLD 4207.30 +0.9% SILVER 57.77 +1.1% COPPER 6.61 +0.8% OIL 95.90 −2.1% PALLADIUM 1129.75 +0.1% OMI 0.250 +0.0% BUFF 0.810 +3.9% FEO 0.650 +0.0% LIB 0.750 +4.2% NPR 0.630 +1.6% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.540 +3.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.55 −2.8% CASA 0.060 +0.0% DRY 0.225 +4.7% SOMA 0.550 −1.8% PWRO 0.025 +0.0%

Healthcare

Page 55
  1. Feb 27, 2026 · 17:22 · SHRX

    Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering

    Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering

    01
  2. Feb 27, 2026 · 17:01 · DTC

    Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million

    Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million

    02
  3. Feb 27, 2026 · 16:35 · NVRS

    JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited

    JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited

    03
  4. Feb 27, 2026 · 16:30 · INNO

    FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

    FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

    04
  5. Feb 27, 2026 · 15:33 · TELO

    Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement

    Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement

    05
  6. Feb 27, 2026 · 11:44 · MDX

    MedX Health closes $2.7-million private placement

    MedX Health closes $2.7-million private placement

    06
  7. Feb 27, 2026 · 07:00 · MDX

    MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes

    MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes

    07
  8. Feb 27, 2026 · 04:52 · BNXT

    Bionxt issues six million shares for debt of $2.7M

    Bionxt issues six million shares for debt of $2.7M

    08
  9. Feb 26, 2026 · 19:00 · BNXT

    BioNxt Announces Closing of Shares for Debt Settlement

    BioNxt Announces Closing of Shares for Debt Settlement

    09
  10. Feb 26, 2026 · 17:17 · EDT

    Spectral delays seeking premarket OK for PMX to mid-May

    Spectral delays seeking premarket OK for PMX to mid-May

    10
  11. Feb 26, 2026 · 17:01 · DTR

    DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx(TM) Red Eye

    DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx(TM) Red Eye

    11
  12. Feb 26, 2026 · 17:00 · EXE

    Extendicare Announces 2025 Fourth Quarter and Full Year Results and Dividend Increase

    Extendicare Announces 2025 Fourth Quarter and Full Year Results and Dividend Increase

    12
  13. Feb 26, 2026 · 16:44 · VIVI

    Tempramed expands U.S. clinician backing

    Tempramed expands U.S. clinician backing

    13
  14. Feb 26, 2026 · 07:30 · EDT

    Spectral Medical Provides Update on PMA Submission Timing for PMX-20R

    Spectral Medical Provides Update on PMA Submission Timing for PMX-20R

    14
← Newer Older →